AI assistant
Lite Strategy, Inc. — Director's Dealing 2021
Jul 7, 2021
34267_dirs_2021-07-06_b43639c5-3687-4eea-89d3-22f8b40fe0ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2021-07-01
Reporting Person: Urso David M (Chief Operating Officer & GC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-02 | Common Stock | F | 24825 | $2.94 | Disposed | 49281 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-01 | Stock Option (Right to Buy) | $2.95 | A | 600000 | Acquired | 2031-07-01 | Common Stock (600000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.57 | 2025-07-28 | Common Stock (127500) | 127500 | Direct |
| Stock Option (Right to Buy) | $1.36 | 2026-07-29 | Common Stock (130000) | 130000 | Direct |
| Stock Option (Right to Buy) | $2.83 | 2027-07-06 | Common Stock (130000) | 130000 | Direct |
| Stock Option (Right to Buy) | $4.33 | 2028-06-22 | Common Stock (130000) | 130000 | Direct |
| Stock Option (Right to Buy) | $4.28 | 2028-07-12 | Common Stock (220000) | 220000 | Direct |
| Stock Option (Right to Buy) | $2.52 | 2029-07-01 | Common Stock (350000) | 350000 | Direct |
| Stock Option (Right to Buy) | $3.49 | 2030-07-02 | Common Stock (525000) | 525000 | Direct |
Footnotes
F1: Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
F2: One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
F3: All of such options are presently exercisable.
F4: One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
F5: One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
F6: One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
F7: One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.